Navigation Links
Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck

First FDA-Approved Artificial Disc For The Cervical Spine Now Available In


TYLER, Texas, Oct. 18 /PRNewswire/ -- Sabatino Bianco, MD, Trinity Clinic Neurosurgeon and Director of the Trinity Mother Frances Neuroscience Institute is the first in the region to offer a new FDA approved cervical arthroplasty implant that can provide some patients a chance to maintain motion in their necks following surgery for cervical degenerative disc disease.


To view the Multimedia News Release, go to:

The new artificial disc, called the PRESTIGE(R) Cervical Disc, is the first artificial disc approved for the cervical spine by the U.S. Food and Drug Administration.

The disc is inserted into the neck using a similar procedure to the technique surgeons use when performing a spinal fusion and is used in a procedure called cervical disc arthroplasty. The new procedure showed superior neurological and overall success outcomes in a recently concluded clinical trial that compared the clinical outcomes of cervical artificial disc replacement (PRESTIGE Cervical Disc) to anterior cervical discectomy and spinal fusion procedures.

"The Prestige Cervical Disc is an exciting new option for my patients," said Dr. Bianco. "This disc may revolutionize treatment options for surgical patients who normally would have only the option of a motion-restricting process of spinal fusion."

In the U.S. clinical trial of the PRESTIGE Cervical disc, patients who received the disc showed improved neurological success at 24 months and improved overall success. The clinical trial is the largest, completed, prospective randomized controlled study of its kind in the cervical spine enrolling a total of 541 patients.

Trinity Mother Frances Health System is comprised of Mother Frances Hospital-Tyler, Mother Frances Hospital-Jacksonville, Trinity Mother Frances Rehabilitation Hospital (affiliated with HealthSouth) and Trinity Clinic, a multi-specialty physician group. The Health System treats patients in many medical specialties, including neurosurgery and robotic-assisted heart procedures.

For more information on the PRESTIGE Cervical disc procedure available at the Trinity Mother Frances Neuroscience Institute, call (903) 525-7995 or visit

SOURCE Trinity Mother Frances Neuroscience Institute
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. A disgusting video: U.S. companies sell out Americans
2. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
3. TomoTherapy opens technical training center
4. TomoTherapy raises $223 million in IPO
5. TomoTherapy revises IPO money target
6. Hospital named for Madame Curie installs TomoTherapy system
7. TomoTherapy files registration statement for IPO
8. TomoTherapy to sell medical devices in India
9. TomoTherapy sees sustained market advantage
10. TomoTherapys 100th radiology system reaches public sector
11. TomoTherapy extends reach to Germany
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):